Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8471)
All Articles published online
|
Apr 28, 2008 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schreuder TC, Verwer BJ, Nieuwkerk CMV, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 2008; 14(16): 2474-2486 [PMID: 18442193 DOI: 10.3748/wjg.14.2474] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i16/2474.htm |
| Number | Citing Articles |
| 1 |
Melissa J Conroy, Vivienne Fitzgerald, Suzanne L Doyle, Shauna Channon, Zivile Useckaite, Niamh Gilmartin, Cliona O’Farrelly, Narayanasamy Ravi, John V Reynolds, Joanne Lysaght. The microenvironment of visceral adipose tissue and liver alter natural killer cell viability and function. Journal of Leukocyte Biology 2016; 100(6): 1435 doi: 10.1189/jlb.5AB1115-493RR
|
| 2 |
Frode Norheim, Simon T. Hui, Emre Kulahcioglu, Margarete Mehrabian, Rita M. Cantor, Calvin Pan, Brian W. Parks, Aldons J. Lusis. Genetic and hormonal control of hepatic steatosis in female and male mice. Journal of Lipid Research 2017; 58(1): 178 doi: 10.1194/jlr.M071522
|
| 3 |
Man-Yi Sun, Li Zhang, Song-Li Shi, Jing-Na Lin, Graham R. Wallace. Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis. PLOS ONE 2016; 11(4): e0154337 doi: 10.1371/journal.pone.0154337
|
| 4 |
Stanislav Kotlyarov. Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease. World Journal of Gastroenterology 2023; 29(4): 597-615 doi: 10.3748/wjg.v29.i4.597
|
| 5 |
Roberto de Cleva, Livio Fiolo Duarte, Milton Roberto Furst Crenitte, Claudia Pinto Marques de Oliveira, Denis Pajecki, Marco Aurelio Santo. Use of noninvasive markers to predict advanced fibrosis/cirrhosis in severe obesity. Surgery for Obesity and Related Diseases 2016; 12(4): 862 doi: 10.1016/j.soard.2015.11.011
|
| 6 |
Mona N. BinMowyna, Nora A. AlFaris, Ekram A. Al-Sanea, Jozaa Z. AlTamimi, Tahany S. Aldayel. Resveratrol attenuates against high-fat-diet-promoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis. Archives of Physiology and Biochemistry 2024; 130(3): 300 doi: 10.1080/13813455.2022.2046106
|
| 7 |
Ellen Schatorjé, Hans Hoekstra. Transient Hypertransaminasemia in Paediatric Patients With Crohn Disease Undergoing Initial Treatment With Enteral Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(3): 336 doi: 10.1097/MPG.0b013e3181d94f63
|
| 8 |
M. Mazaki‐Tovi, S.K. Abood, G. Segev, P.A. Schenck. Alterations in Adipokines in Feline Hepatic Lipidosis. Journal of Veterinary Internal Medicine 2013; 27(2): 242 doi: 10.1111/jvim.12055
|
| 9 |
Krushna Baviskar, Aniket Kshirsagar, Hemant Raut, M.R.N Shaikh. Overview: Global burden of liver disease. International Journal of Pharmaceutical Chemistry and Analysis 2024; 11(1): 1 doi: 10.18231/j.ijpca.2024.001
|
| 10 |
Birgit Knebel, Jutta Haas, Sonja Hartwig, Sylvia Jacob, Cornelia Köllmer, Ulrike Nitzgen, Dirk Muller–Wieland, Jorg Kotzka, Sunil K. Ahuja. Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass. PLoS ONE 2012; 7(2): e31812 doi: 10.1371/journal.pone.0031812
|
| 11 |
Xiaoyu Liao, Lingyu Song, Linlin Zhang, Hui Wang, Qiang Tong, Jing Xu, Gangyi Yang, Shiming Yang, Hongting Zheng. LAMP3 regulates hepatic lipid metabolism through activating PI3K/Akt pathway. Molecular and Cellular Endocrinology 2018; 470: 160 doi: 10.1016/j.mce.2017.10.010
|
| 12 |
Vincent R. Sauvage, Adam P. Levene, Hoa T. Nguyen, Tobias C. Wood, Hiromi Kudo, Danilo Concas, Howard C. Thomas, Mark R. Thursz, Robert D. Goldin, Quentin M. Anstee, Daniel S. Elson. Multi‐excitation fluorescence spectroscopy for analysis of non‐alcoholic fatty liver disease. Lasers in Surgery and Medicine 2011; 43(5): 392 doi: 10.1002/lsm.21064
|
| 13 |
Christopher T. Barry, Bradley Mills, Zaegyoo Hah, Robert A. Mooney, Charlotte K. Ryan, Deborah J. Rubens, Kevin J. Parker. Shear Wave Dispersion Measures Liver Steatosis. Ultrasound in Medicine & Biology 2012; 38(2): 175 doi: 10.1016/j.ultrasmedbio.2011.10.019
|
| 14 |
Yeaji Park, Jeehye Sung, Jinwoo Yang, Hyeonmi Ham, Younghwa Kim, Heon-Sang Jeong, Junsoo Lee. Inhibitory effect of esculetin on free-fatty-acid-induced lipid accumulation in human HepG2 cells through activation of AMP-activated protein kinase. Food Science and Biotechnology 2017; 26(1): 263 doi: 10.1007/s10068-017-0035-0
|
| 15 |
Yue Xu, Lin-Lin Lu, Shou-Sheng Liu, Shui-Xian Du, Hui-Ling Zhu, Quan-Jiang Dong, Yong-Ning Xin. Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2018; 17(3): 214 doi: 10.1016/j.hbpd.2018.04.004
|
| 16 |
Jae-Seong Yang, Jin Taek Kim, Jouhyun Jeon, Ho Sun Park, Gyeong Hoon Kang, Kyong Soo Park, Hong Kyu Lee, Sanguk Kim, Young Min Cho, Thorkild I. A. Sorensen. Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice. PLoS ONE 2010; 5(11): e13858 doi: 10.1371/journal.pone.0013858
|
| 17 |
Thing-Fong Tzeng, Shorong-Shii Liou, Chia Ju Chang, I-Min Liu. Zerumbone, a Natural Cyclic Sesquiterpene ofZingiber zerumbetSmith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat Diet. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/303061
|
| 18 |
Sudhakar Kundapur Venkatesh, Scott B. Reeder. New and Improved Imaging Modalities for NAFLD. Current Hepatology Reports 2014; 13(2): 88 doi: 10.1007/s11901-014-0212-z
|
| 19 |
Sylene Coutinho Rampche de Carvalho, Maria Tereza Cartaxo Muniz, Maria Deozete Vieira Siqueira, Erika Rabelo Forte Siqueira, Adriana Vieira Gomes, Karina Alves Silva, Laís Carvalho Luma Bezerra, Vânia D’Almeida, Claudia Pinto Marques Souza de Oliveira, Leila Maria M Beltrão Pereira. Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD). Nutrition Journal 2013; 12(1) doi: 10.1186/1475-2891-12-37
|
| 20 |
Erwin-Jan M. van Geenen, Mark M. Smits, Tim C.M.A. Schreuder, Donald L. van der Peet, Elisabeth Bloemena, Chris J.J. Mulder. Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease. Pancreas 2010; 39(8): 1185 doi: 10.1097/MPA.0b013e3181f6fce2
|
| 21 |
Elena Buzzetti, Massimo Pinzani, Emmanuel A. Tsochatzis. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016; 65(8): 1038 doi: 10.1016/j.metabol.2015.12.012
|
| 22 |
Seung-Ju Hwang, Yu-Jin Choi, Jing-Hua Wang, Chang-Gue Son. Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model. Biomedicine & Pharmacotherapy 2024; 172: 116250 doi: 10.1016/j.biopha.2024.116250
|
| 23 |
Mark M Smits, George N Ioannou, Edward J Boyko, Kristina M Utzschneider. Non‐alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups. Journal of Gastroenterology and Hepatology 2013; 28(4): 664 doi: 10.1111/jgh.12106
|
| 24 |
Vlad Ratziu, Victor de Ledinghen, Fréderic Oberti, Philippe Mathurin, Claire Wartelle-Bladou, Christophe Renou, Philippe Sogni, Marianne Maynard, Dominique Larrey, Lawrence Serfaty, Dominique Bonnefont-Rousselot, Jean-Philippe Bastard, Marc Rivière, Jean Spénard. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. Journal of Hepatology 2011; 54(5): 1011 doi: 10.1016/j.jhep.2010.08.030
|
| 25 |
Katherine J. P. Schwenger, Colin M. Bolzon, Carrie Li, Johane P. Allard. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. European Journal of Nutrition 2019; 58(5): 1771 doi: 10.1007/s00394-018-1844-5
|
| 26 |
Andrew Smith, Ahmad Elnahas, Allan Okrainec, Fayez A. Quereshy, Timothy D. Jackson. Is Bariatric Surgery Safe in Patients with Cirrhosis? An Analysis of Short-Term Outcomes. Bariatric Surgical Practice and Patient Care 2015; 10(1): 19 doi: 10.1089/bari.2014.0034
|
| 27 |
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, Pia Clara Pafundi, Raffaele Galiero, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdinando Carlo Sasso. Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact. Processes 2021; 9(1): 135 doi: 10.3390/pr9010135
|
| 28 |
Fabien Forcheron, Pauline Abdallah, Alexandra Basset, Peggy del Carmine, Ghina Haffar, Michel Beylot. Nonalcoholic Hepatic Steatosis in Zucker Diabetic Rats: Spontaneous Evolution and Effects of Metformin and Fenofibrate. Obesity 2009; 17(7): 1381 doi: 10.1038/oby.2008.661
|
| 29 |
Paula J. Bartlett, Lawrence D. Gaspers, Nicola Pierobon, Andrew P. Thomas. Calcium-dependent regulation of glucose homeostasis in the liver. Cell Calcium 2014; 55(6): 306 doi: 10.1016/j.ceca.2014.02.007
|
| 30 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
|
| 31 |
Simon T Hui, Brian W Parks, Elin Org, Frode Norheim, Nam Che, Calvin Pan, Lawrence W Castellani, Sarada Charugundla, Darwin L Dirks, Nikolaos Psychogios, Isaac Neuhaus, Robert E Gerszten, Todd Kirchgessner, Peter S Gargalovic, Aldons J Lusis. The genetic architecture of NAFLD among inbred strains of mice. eLife 2015; 4 doi: 10.7554/eLife.05607
|
| 32 |
Claudia D. Fuchs, Thierry Claudel, Pooja Kumari, Guenter Haemmerle, Marion J. Pollheimer, Tatjana Stojakovic, Hubert Scharnagl, Emina Halilbasic, Judith Gumhold, Dagmar Silbert, Harald Koefeler, Michael Trauner. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology 2012; 56(1): 270 doi: 10.1002/hep.25601
|
| 33 |
Treatment of non-alcoholic fatty liver disease in children: swim at your own risk. Pediatric Diabetes 2009; 10(1): 1 doi: 10.1111/j.1399-5448.2008.00488.x
|
| 34 |
Yong-Ning Xin, Shi-Ying Xuan, Jian-Hua Zhang, Ming-Hua Zheng, Hua-Shi Guan. Omega-3 polyunsaturated fatty acids: A specific liver drug for non-alcoholic fatty liver disease (NAFLD). Medical Hypotheses 2008; 71(5): 820 doi: 10.1016/j.mehy.2008.07.008
|
| 35 |
Vera S. G. Ferreira, Ricardo B. Pernambuco, Edmundo P. Lopes, Clarice N. Morais, Marbiana C. Rodrigues, Maria Juliana Arruda, Lidiane Moura e Silva, Lucio Vilar. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arquivos Brasileiros de Endocrinologia & Metabologia 2010; 54(4): 362 doi: 10.1590/S0004-27302010000400004
|
| 36 |
Abdullah S. Shatoor, Suliman Al Humayed, Hussain M. Almohiy. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2. Journal of Physiology and Biochemistry 2022; 78(1): 151 doi: 10.1007/s13105-021-00850-9
|
| 37 |
Heather M. Alger, J. Mark Brown, Janet K. Sawyer, Kathryn L. Kelley, Ramesh Shah, Martha D. Wilson, Mark C. Willingham, Lawrence L. Rudel. Inhibition of Acyl-Coenzyme A:Cholesterol Acyltransferase 2 (ACAT2) Prevents Dietary Cholesterol-associated Steatosis by Enhancing Hepatic Triglyceride Mobilization. Journal of Biological Chemistry 2010; 285(19): 14267 doi: 10.1074/jbc.M110.118422
|
| 38 |
Zeynab Sheybani Asl, Ali Akbar Malekirad, Mohammad Abdollahi, Alireza Bakhshipour, Hajar Akbari Dastjerdi, Sara Mostafalou, Razieh Yousef Poor. Effects of the Mixture of <i>Cichorium intybus</i> L. and <i>Cinnamomum zeylanicum</i> on Hepatic Enzymes Activity and Biochemical Parameters in Patients with Nonalcoholic Fatty Liver Disease. Health 2014; 6(11): 1212 doi: 10.4236/health.2014.611148
|
| 39 |
Toshiaki Gunji, Nobuyuki Matsuhashi, Hajime Sato, Kazutoshi Fujibayashi, Mitsue Okumura, Noriko Sasabe, Akio Urabe. Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population. The American Journal of Gastroenterology 2009; 104(9): 2189 doi: 10.1038/ajg.2009.361
|
| 40 |
Tsunehiro Ochi, Kensuke Munekage, Masafumi Ono, Takuma Higuchi, Masayuki Tsuda, Yoshihiro Hayashi, Nobuto Okamoto, Katsumi Toda, Shuji Sakamoto, Jude A. Oben, Toshiji Saibara. Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in mice. Hepatology Research 2016; 46(6): 584 doi: 10.1111/hepr.12587
|
| 41 |
Yongqing Zhou, Chuanchen Wu, Xin Wang, Ping Li, Nannan Fan, Wei Zhang, Zhenzhen Liu, Wen Zhang, Bo Tang. Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. Analytical Chemistry 2021; 93(27): 9609 doi: 10.1021/acs.analchem.1c01776
|
| 42 |
Ignacio Ayala, Antonia Martín Castillo, Gracia Adánez, Ana Fernández-Rufete, Bartolomé García Pérez, Maria T. Castells. Hyperlipidemic Chicken as a Model of Non-Alcoholic Steatohepatitis. Experimental Biology and Medicine 2009; 234(1): 10 doi: 10.3181/0807-RM-219
|
| 43 |
Yoosoo Chang, Seungho Ryu, Yiyi Zhang, Hee Jung Son, Jang-Young Kim, Juhee Cho, Eliseo Guallar, Anthony W.I. Lo. A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean Workers. PLoS ONE 2012; 7(5): e37241 doi: 10.1371/journal.pone.0037241
|
| 44 |
Biswajit Mukherjee, Chowdhury M. Hossain, Laboni Mondal, Paramita Paul, Miltu K. Ghosh. Obesity and Insulin Resistance: An Abridged Molecular Correlation. Lipid Insights 2013; 6 doi: 10.4137/LPI.S10805
|
| 45 |
Sabrena F. Noria, James A. Rydlewicz, Dean J. Mikami, Bradley J. Needleman. Glucose Intake and Utilization in Pre-Diabetes and Diabetes. 2015; : 71 doi: 10.1016/B978-0-12-800093-9.00006-5
|
| 46 |
Kevin J. Parker, Alexander Partin, Deborah J. Rubens. What Do We Know About Shear Wave Dispersion in Normal and Steatotic Livers?. Ultrasound in Medicine & Biology 2015; 41(5): 1481 doi: 10.1016/j.ultrasmedbio.2015.01.002
|
| 47 |
Rajasekhara R. Mummadi, Krishna S. Kasturi, Swapna Chennareddygari, Gagan K. Sood. Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology 2008; 6(12): 1396 doi: 10.1016/j.cgh.2008.08.012
|
| 48 |
M. Mazaki-Tovi, S. R. Bolin, P. A. Schenck. Adipokines secretion in feline primary adipose tissue culture in response to dietary fatty acids. BMC Veterinary Research 2019; 15(1) doi: 10.1186/s12917-019-2065-8
|
| 49 |
Zaida Zakaria, Zaidatul Akmal Othman, Joseph Bagi Suleiman, Nur Asyilla Che Jalil, Wan Syaheedah Wan Ghazali, Mahaneem Mohamed. Protective and Therapeutic Effects of Orlistat on Metabolic Syndrome and Oxidative Stress in High-Fat Diet-Induced Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Rats: Role on Nrf2 Activation. Veterinary Sciences 2021; 8(11): 274 doi: 10.3390/vetsci8110274
|
| 50 |
Yong Pil Hwang, Hyung Gyun Kim, Jae Ho Choi, Minh Truong Do, Young Chul Chung, Tae Cheon Jeong, Hye Gwang Jeong. S-Allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. The Journal of Nutritional Biochemistry 2013; 24(8): 1469 doi: 10.1016/j.jnutbio.2012.12.006
|
| 51 |
Sana Raza, Archana Tewari, Sangam Rajak, Rohit A. Sinha. Vitamins and non-alcoholic fatty liver disease: A molecular insight. Liver Research 2021; 5(2): 62 doi: 10.1016/j.livres.2021.03.004
|
| 52 |
Rosane Ness‐Abramof, Caroline M. Apovian. Waist Circumference Measurement in Clinical Practice. Nutrition in Clinical Practice 2008; 23(4): 397 doi: 10.1177/0884533608321700
|
| 53 |
Waleed Samy, Mohammed A. Hassanian. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. Arab Journal of Gastroenterology 2011; 12(2): 80 doi: 10.1016/j.ajg.2011.04.008
|
| 54 |
Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-018-0877-3
|
| 55 |
A. Schneider, M. Momma. Folgeerkrankungen und Komplikationen der Adipositas. Der Gastroenterologe 2008; 3(5): 391 doi: 10.1007/s11377-008-0204-z
|
| 56 |
Radojica V. Stolic, Goran Z. Trajkovic, Mirjana M. Kostic, Sasa R. Sovtic, Andrijana M. Odalovic, Biljana D. Krdzic, Maja V. Sipic, Snezana Lazic, Zorica N. Sojevic-Timotijevic. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients. International Urology and Nephrology 2016; 48(6): 883 doi: 10.1007/s11255-016-1237-8
|
| 57 |
Yongqing Zhou, Ping Li, Xin Wang, Chuanchen Wu, Nannan Fan, Xiaoning Liu, Lijie Wu, Wei Zhang, Wen Zhang, Zhenzhen Liu, Bo Tang. In situvisualization of peroxisomal viscosity in the liver of mice with non-alcoholic fatty liver disease by near-infrared fluorescence and photoacoustic imaging. Chemical Science 2020; 11(44): 12149 doi: 10.1039/D0SC02922J
|
| 58 |
Julien Calderaro, Elie Serge Zafrani. Stéatopathie hépatique non alcoolique. Annales de Pathologie 2010; 30(6): 413 doi: 10.1016/j.annpat.2010.10.002
|
| 59 |
Dirk Müller-Wieland, Birgit Knebel, Jutta Haas, Martin Merkel, Jörg Kotzka. Adipositas: ektope Fettverteilung und Herz. Herz 2010; 35(3): 198 doi: 10.1007/s00059-010-3344-0
|
| 60 |
Cuiying Chen, Hemda Schmilovitz-Weiss, Xue-en Liu, Orit Pappo, Marisa Halpern, Jaqueline Sulkes, Marius Braun, Maya Cohen, Nir Barak, Ran Tur-Kaspa, Valerie Vanhooren, Hans Van Vlierberghe, Claude Libert, Roland Contreras, Ziv Ben-Ari. Serum Protein N-Glycans Profiling for the Discovery of Potential Biomarkers for Nonalcoholic Steatohepatitis. Journal of Proteome Research 2009; 8(2): 463 doi: 10.1021/pr800656e
|
| 61 |
Stein Emil Vollset. Risk and causes of death between 40 and 70 years of age in the Nordic countries 1951–2010. Scandinavian Journal of Public Health 2013; 41(6): 644 doi: 10.1177/1403494813491032
|
| 62 |
Satoshi Kajikawa, Tsuyoshi Harada, Akiko Kawashima, Kazunori Imada, Kiyoshi Mizuguchi. Highly Purified Eicosapentaenoic Acid Ethyl Ester Prevents Development of Steatosis and Hepatic Fibrosis in Rats. Digestive Diseases and Sciences 2010; 55(3): 631 doi: 10.1007/s10620-009-1020-0
|
| 63 |
Kyong Yeun Jung, Sun Young Cho, Hyung Joon Kim, Suk Bae Kim, Il Han Song. Nonalcoholic Steatohepatitis Associated With Metabolic Syndrome. Journal of Clinical Gastroenterology 2014; 48(10): 883 doi: 10.1097/MCG.0000000000000065
|
| 64 |
Waleed Samy Mohamed. Metabolic Effects of Foenugreek, Nigella and Termis: Review Article. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 2016; 3: 90 doi: 10.18052/www.scipress.com/IJPPE.3.90
|
| 65 |
Claudio Maffeis, Claudia Banzato, Francesca Rigotti, Valerio Nobili, Silvia Valandro, Riccardo Manfredi, Anita Morandi. Biochemical Parameters and Anthropometry Predict NAFLD in Obese Children. Journal of Pediatric Gastroenterology and Nutrition 2011; 53(6): 590 doi: 10.1097/MPG.0b013e31822960be
|
| 66 |
Christopher T. Barry, Christopher Hazard, Zaegyoo Hah, Gang Cheng, Alexander Partin, Robert A. Mooney, Kuang-Hsiang Chuang, Wenqing Cao, Deborah J. Rubens, Kevin J. Parker. Shear Wave Dispersion in Lean Versus Steatotic Rat Livers. Journal of Ultrasound in Medicine 2015; 34(6): 1123 doi: 10.7863/ultra.34.6.1123
|
| 67 |
Konstantinos Kargiotis, Vasilios G Athyros, Olga Giouleme, Niki Katsiki, Evangelia Katsiki, Panagiotis Anagnostis, Chrysoula Boutari, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. World Journal of Gastroenterology 2015; 21(25): 7860-7868 doi: 10.3748/wjg.v21.i25.7860
|
| 68 |
TAKUMI ONOYAMA, MASAHIKO KODA, TOSHIAKI OKAMOTO, MANABU KISHINA, TOMOMITSU MATONO, TAKAAKI SUGIHARA, YOSHIKAZU MURAWAKI. Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice. Molecular Medicine Reports 2015; 12(5): 6895 doi: 10.3892/mmr.2015.4329
|
| 69 |
Gaoxuan Shao, Ying Liu, Lu Lu, Guangtao Zhang, Wenjun Zhou, Tao Wu, Lei Wang, Hanchen Xu, Guang Ji. The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.944088
|
| 70 |
Ümit Karaoğullarindan, Oguz Üsküdar, Emre Odabaş, Melike Saday, Gamze Akkuş, Anil Delik, Yüksel Gümürdülü, Sedef Kuran. Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?. Indian Journal of Gastroenterology 2023; 42(2): 219 doi: 10.1007/s12664-022-01330-8
|
| 71 |
Natalie E. VandenAkker, Stefano Vendrame, Panagiotis Tsakiroglou, Marissa McGilvrey, Dorothy Klimis-Zacas. Whole Red Raspberry (Rubus idaeus)-Enriched Diet Is Hepatoprotective in the Obese Zucker Rat, a Model of the Metabolic Syndrome. Journal of Medicinal Food 2021; 24(8): 817 doi: 10.1089/jmf.2020.0130
|
| 72 |
Aicha Labdi, Malek Amiali, Yacine Nait Bachir, Abdelaziz Merouane, Amina Dahman-Zouambi, Elhadj Ahmed Koceir, Arezki Bitam. Green tea extract attenuates non alcoholic fatty liver disease by decreasing hyperlipidemia and enhancing Superoxide dismutase activity in cholesterol-fed rats. Mediterranean Journal of Nutrition and Metabolism 2018; 11(3): 295 doi: 10.3233/MNM-180227
|
| 73 |
Omar Elshaarawy, Johannes Mueller, Sina Straub, Sebastian Mueller. Nicht-alkoholische Fettlebererkrankung. 2022; : 137 doi: 10.1007/978-3-662-62484-5_13
|
| 74 |
John P. Duffy, Johnny C. Hong, Douglas G. Farmer, Rafik M. Ghobrial, Hasan Yersiz, Jonathan R. Hiatt, Ronald W. Busuttil. Vascular Complications of Orthotopic Liver Transplantation: Experience in More than 4,200 Patients. Journal of the American College of Surgeons 2009; 208(5): 896 doi: 10.1016/j.jamcollsurg.2008.12.032
|
| 75 |
Anna Kotronen, Markku Peltonen, Antti Hakkarainen, Ksenia Sevastianova, Robert Bergholm, Lina M. Johansson, Nina Lundbom, Aila Rissanen, Martin Ridderstråle, Leif Groop, Marju Orho–Melander, Hannele Yki–Järvinen. Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors. Gastroenterology 2009; 137(3): 865 doi: 10.1053/j.gastro.2009.06.005
|
| 76 |
Kavitha Bhat Schelbert. Comorbidities of Obesity. Primary Care: Clinics in Office Practice 2009; 36(2): 271 doi: 10.1016/j.pop.2009.01.009
|
| 77 |
Vineeta Sharma, Robert O. Ryan, Trudy M. Forte. Apolipoprotein A-V dependent modulation of plasma triacylglycerol: A puzzlement. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2012; 1821(5): 795 doi: 10.1016/j.bbalip.2011.12.002
|
| 78 |
Jamie E. Mells, Ping P. Fu, Pradeep Kumar, Tekla Smith, Saul J. Karpen, Frank A. Anania. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. The Journal of Nutritional Biochemistry 2015; 26(3): 285 doi: 10.1016/j.jnutbio.2014.11.002
|
| 79 |
Disha Zou, Yao Ye, Nina Zou, Jian Yu. Analysis of risk factors and their interactions in type 2 diabetes mellitus: A cross‐sectional survey in Guilin, China. Journal of Diabetes Investigation 2017; 8(2): 188 doi: 10.1111/jdi.12549
|
| 80 |
Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon 2024; 10(7): e28468 doi: 10.1016/j.heliyon.2024.e28468
|
| 81 |
M. Susan Mandell, Michael Zimmerman, Jeffrey Campsen, Igal Kam. Bariatric Surgery in Liver Transplant Patients: Weighing the Evidence. Obesity Surgery 2008; 18(12): 1515 doi: 10.1007/s11695-008-9712-7
|
| 82 |
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
|
| 83 |
Mario Arciello, Alessia Longo, Carmela Viscomi, Concetta Capo, Antonio Angeloni, Luisa Rossi, Clara Balsano. Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload. BioMetals 2015; 28(6): 1017 doi: 10.1007/s10534-015-9886-0
|
| 84 |
Hanxiang Zhong. Non-alcoholic fatty liver disease: pathogenesis and models. American Journal of Translational Research 2024; 16(2): 387 doi: 10.62347/KMSA5983
|
| 85 |
Bruna M. Schweinberger, Angela T. S. Wyse. Mechanistic basis of hypermethioninemia. Amino Acids 2016; 48(11): 2479 doi: 10.1007/s00726-016-2302-4
|
| 86 |
Bora Lee, Eun‐Ae Jung, Jeong‐Ju Yoo, Sang Gyune Kim, Cheon‐Beom Lee, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Baek Gyu Jun, Young Don Kim, Gab Jin Cheon. Prevalence, incidence and risk factors of tamoxifen‐related non‐alcoholic fatty liver disease: A systematic review and meta‐analysis. Liver International 2020; 40(6): 1344 doi: 10.1111/liv.14434
|
| 87 |
Kameliya Bratoeva, Silviya Nikolova, Albena Merdzhanova, George St. Stoyanov, Eleonora Dimitrova, Javor Kashlov, Nikolay Conev, Mariya Radanova. Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2018; 16(7): 350 doi: 10.1089/met.2017.0162
|
| 88 |
Hana Malínská, Olena Oliyarnyk, Miriam Hubová, Václav Zídek, Vladimír Landa, Miroslava Šimáková, Petr Mlejnek, Ludmila Kazdová, Theodore W. Kurtz, Michal Pravenec. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. Molecular and Cellular Biochemistry 2010; 335(1-2): 119 doi: 10.1007/s11010-009-0248-5
|
| 89 |
Anatoly I. Bozhkov, Rustam A. Akzhyhitov, Svitlana G. Bilovetska, Evgeny G. Ivanov, Nataliia I. Dobrianska, Anastasiia Yu Bondar. The Effect of Retinol Acetate on Liver Fibrosis Depends on the Temporal Features of the Development of Pathology. Journal of Clinical and Experimental Hepatology 2024; 14(3): 101338 doi: 10.1016/j.jceh.2023.101338
|
| 90 |
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver disease. World Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
|
| 91 |
Erim Gulcan, Lokman Koral, Fatih Oghan. Nonalcoholic steatohepatitis may increase the tendency to development of osteoporosis by decreasing bone mineral density. Bioscience Hypotheses 2009; 2(3): 178 doi: 10.1016/j.bihy.2009.02.004
|
| 92 |
Yi-Lin Tsai, Sean Chun-Chang Chen. Joint effect of changes in physical activity and weight on incident non-alcoholic fatty liver disease. Journal of Epidemiology and Community Health 2021; 75(12): 1215 doi: 10.1136/jech-2021-216728
|
| 93 |
Monika Ciupińska-Kajor, Marek Hartleb, Maciej Kajor, Michał Kukla, Mariusz Wyleżoł, Dariusz Lange, Łukasz Liszka. Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. Hepatology International 2013; 7(1): 233 doi: 10.1007/s12072-011-9320-9
|
| 94 |
Surim Park, Jong Won Kim, Hyejin Yun, Seong-Jin Choi, Sang-Hyub Lee, Kyung-Chul Choi, Chae Woong Lim, Kyuhong Lee, Bumseok Kim. Mainstream cigarette smoke accelerates the progression of nonalcoholic steatohepatitis by modulating Kupffer cell-mediated hepatocellular apoptosis in adolescent mice. Toxicology Letters 2016; 256: 53 doi: 10.1016/j.toxlet.2016.05.012
|
| 95 |
Charlotte Burelle, Valentin Clapatiuc, Sonia Deschênes, Alexanne Cuillerier, Marine De Loof, Marie-Ève Higgins, Hugues Boël, Caroline Daneault, Billie Chouinard, Marie-Élaine Clavet, Nolwenn Tessier, Isabelle Croteau, Geneviève Chabot, Catherine Martel, Martin G. Sirois, Sylvie Lesage, Yan Burelle, Matthieu Ruiz. A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis. Communications Biology 2024; 7(1) doi: 10.1038/s42003-024-06035-6
|
| 96 |
Nathan M. Bass. Lipidomic Dissection of Nonalcoholic Steatohepatitis: Moving Beyond Foie Gras to Fat Traffic. Hepatology 2010; 51(1): 4 doi: 10.1002/hep.23458
|
| 97 |
Sevtap Kılınç, Pelin Şahin, Zeynep Yığman, Ayşe Meltem Sevgili. Topiramate’s effects on normal and fatty liver. Drug and Chemical Toxicology 2024; 47(5): 729 doi: 10.1080/01480545.2023.2276083
|
| 98 |
Corinna Koebnick, Darios Getahun, Kristi Reynolds, Karen J Coleman, Amy H Porter, Jean M Lawrence, Mark Punyanitya, Virginia P Quinn, Steven J Jacobsen. Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults. Journal of Pediatric Gastroenterology and Nutrition 2009; 48(5): 597 doi: 10.1097/MPG.0b013e318192d224
|
| 99 |
Yeon Woo Lee, Christina D. Yarrington. Obstetric Outcomes in Women with Nonalcoholic Fatty Liver Disease. Metabolic Syndrome and Related Disorders 2017; 15(8): 387 doi: 10.1089/met.2017.0058
|
| 100 |
Maciej Henneberg, Frank J. Rühli, Philipp Gruber, Ulrich Woitek. Alanine Transaminase Individual Variation Is a Better Marker than Socio-Cultural Factors for Body Mass Increase in Healthy Males. Food and Nutrition Sciences 2011; 2(10): 1054 doi: 10.4236/fns.2011.210141
|
| 101 |
U. Rajendra Acharya, Oliver Faust, Filippo Molinari, S. Vinitha Sree, Sameer P. Junnarkar, Vidya Sudarshan. Ultrasound-based tissue characterization and classification of fatty liver disease: A screening and diagnostic paradigm. Knowledge-Based Systems 2015; 75: 66 doi: 10.1016/j.knosys.2014.11.021
|
| 102 |
Feng-Shang Zhu, Su Liu, Xi-Mei Chen, Zhi-Gang Huang, Dong-Wei Zhang. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World Journal of Gastroenterology 2008; 14(41): 6395-6400 doi: 10.3748/wjg.14.6395
|
| 103 |
Christopher T. Barry, Zaegyoo Hah, Alexander Partin, Robert A. Mooney, Kuang-Hsiang Chuang, Alicia Augustine, Anthony Almudevar, Wenqing Cao, Deborah J. Rubens, Kevin J. Parker. Mouse Liver Dispersion for the Diagnosis of Early-Stage Fatty Liver Disease: A 70-Sample Study. Ultrasound in Medicine & Biology 2014; 40(4): 704 doi: 10.1016/j.ultrasmedbio.2013.10.016
|
| 104 |
Claudia D. Fuchs, Richard Radun, Emmanuel D. Dixon, Veronika Mlitz, Gerald Timelthaler, Emina Halilbasic, Merima Herac, Johan W. Jonker, Onne A. H. O. Ronda, Matteo Tardelli, Guenter Haemmerle, Robert Zimmermann, Hubert Scharnagl, Tatjana Stojakovic, Henkjan J. Verkade, Michael Trauner. Hepatocyte‐specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin‐like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice. Hepatology 2022; 75(1): 125 doi: 10.1002/hep.32112
|
| 105 |
Mohammad Hashemi, Ebrahim Eskandari-Nasab, Aliakbar Fazaeli, Ali Bahari, Noor-Allah Hashemzehi, Sara Shafieipour, Mohsen Taheri, Abdolkarim Moazeni-Roodi, Zahra Zakeri, Alireza Bakhshipour, Saeid Ghavami. Association of Genetic Polymorphisms of Glutathione-S-Transferase Genes (GSTT1, GSTM1, and GSTP1) and Susceptibility to Nonalcoholic Fatty Liver Disease in Zahedan, Southeast Iran. DNA and Cell Biology 2012; 31(5): 672 doi: 10.1089/dna.2011.1343
|
| 106 |
Ratanesh Kumar Seth, Diana Kimono, Firas Alhasson, Sutapa Sarkar, Muayad Albadrani, Stephen K. Lasley, Ronnie Horner, Patricia Janulewicz, Mitzi Nagarkatti, Prakash Nagarkatti, Kimberly Sullivan, Saurabh Chatterjee. Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness. Toxicology and Applied Pharmacology 2018; 350: 64 doi: 10.1016/j.taap.2018.05.006
|
| 107 |
Erwin J. M. van Geenen, Donald L. van der Peet, Pranav Bhagirath, Chris J. J. Mulder, Marco J. Bruno. Etiology and diagnosis of acute biliary pancreatitis. Nature Reviews Gastroenterology & Hepatology 2010; 7(9): 495 doi: 10.1038/nrgastro.2010.114
|
| 108 |
Yoshiyuki Sasaki, Tsutomu Shimada, Seiichi Iizuka, Wataru Suzuki, Hiroko Makihara, Ryutaro Teraoka, Koichi Tsuneyama, Ryoji Hokao, Masaki Aburada. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. European Journal of Pharmacology 2011; 662(1-3): 1 doi: 10.1016/j.ejphar.2011.04.051
|
| 109 |
MI KYUNG NAM, HYE RAN CHOI, JIN SOOK CHO, SOO MIN CHO, KI CHAN HA, TAE-HYEON KIM, HEE-YOUNG RYU, YOUNG-IK LEE. Inhibitory effects of Rubi Fructus extracts on hepatic steatosis development in high-fat diet-induced obese mice. Molecular Medicine Reports 2014; 10(4): 1821 doi: 10.3892/mmr.2014.2398
|
| 110 |
Simone Coghetto Acedo, Cintia Rabelo e Paiva Caria, Érica Martins Ferreira Gotardo, José Aires Pereira, José Pedrazzoli, Marcelo Lima Ribeiro, Alessandra Gambero. Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice. World Journal of Hepatology 2015; 7(24): 2551-2558 doi: 10.4254/wjh.v7.i24.2551
|
| 111 |
Mustafa Koplay, Erim Gulcan, Fuat Ozkan. Association between Serum Vitamin B12 Levels and the Degree of Steatosis in Patients with Nonalcoholic Fatty Liver Disease. Journal of Investigative Medicine 2011; 59(7): 1137 doi: 10.2310/JIM.0b013e31822a29f5
|
| 112 |
Antonia Martín-Castillo, Maria Teresa Castells, Gracia Adánez, Maria Teresa Sánchez Polo, Bartolomé García Pérez, Ignacio Ayala. Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. Biomedicine & Pharmacotherapy 2010; 64(4): 275 doi: 10.1016/j.biopha.2009.06.003
|
| 113 |
Hakan Ozhan, Mesut Aydin, Mehmet Yazici, Omer Yazgan, Cengiz Basar, Adem Gungor, Elif Onder. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets 2010; 21(1): 29 doi: 10.3109/09537100903391023
|
| 114 |
Ki-Chul Sung, Bum-Soo Kim, Yong-Kyun Cho, Dong-il Park, Sookyoung Woo, Seonwoo Kim, Sarah H Wild, Christopher D Byrne. Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-84
|
| 115 |
Toshinori Kamisako, Yuji Tanaka, Yoshizumi Kishino, Takanori Ikeda, Kazuo Yamamoto, Shiori Masuda, Hiroshi Ogawa. Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice. Journal of Clinical Biochemistry and Nutrition 2014; 54(2): 90 doi: 10.3164/jcbn.13-92
|
| 116 |
Waleed S. Mohamed, Ashraf M. Mostafa, Khaled M. Mohamed, Abdel Hamid Serwah. Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats. Arab Journal of Gastroenterology 2015; 16(1): 1 doi: 10.1016/j.ajg.2014.12.003
|
| 117 |
Qin Pan, Mei-Mei Chen, Rui-Nan Zhang, Yu-Qin Wang, Rui-Dan Zheng, Yu-Qiang Mi, Wen-Bin Liu, Feng Shen, Qing Su, Jian-Gao Fan. PNPLA3rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/4740124
|
| 118 |
Antônio Sérgio Barcala Jorge, João Marcus Oliveira Andrade, Alanna Fernandes Paraíso, Gislaine Candida Batista Jorge, Christine Mendes Silveira, Ludmilla Regina de Souza, Erivelton Pereira Santos, André Luiz Sena Guimaraes, Sérgio Henrique Sousa Santos, Alfredo Maurício Batista De-Paula. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity. Obesity Research & Clinical Practice 2018; 12(1): 1 doi: 10.1016/j.orcp.2016.03.009
|
| 119 |
Jorg Kotzka, Birgit Knebel, Jutta Haas, Lorena Kremer, Sylvia Jacob, Sonja Hartwig, Ulrike Nitzgen, Dirk Muller–Wieland, Stephane Blanc. Preventing Phosphorylation of Sterol Regulatory Element-Binding Protein 1a by MAP-Kinases Protects Mice from Fatty Liver and Visceral Obesity. PLoS ONE 2012; 7(2): e32609 doi: 10.1371/journal.pone.0032609
|
| 120 |
Giovanni Guaraldi, Giulia Besutti, Chiara Stentarelli, Stefano Zona, Luca Nocetti, Paola Loria, Stefano Ballestri, Luisa Losi, Pietro Torricelli, Guido Ligabue. Magnetic Resonance for Quantitative Assessment of Liver Steatosis: A New Potential Tool to Monitor Antiretroviral-Drug-Related Toxicities. Antiviral Therapy 2012; 17(6): 965 doi: 10.3851/IMP2228
|
| 121 |
Sheeno P. Thyparambil, Ricky D. Edmondson, Yvonne P. Dragan. Hepatocellular Carcinoma. 2009; : 55 doi: 10.1007/978-1-60327-376-3_3
|
| 122 |
Ganka Bekyarova, Maria Tzaneva, Kamelia Bratoeva, Irina Ivanova, Andrei Kotzev, Minka Hristova, Dimo Krastev, Ivan Kindekov, Milka Mileva. 4-Hydroxynonenal (HNE) and hepatic injury related to chronic oxidative stress. Biotechnology & Biotechnological Equipment 2019; 33(1): 1544 doi: 10.1080/13102818.2019.1674690
|
| 123 |
Duminda Suraweera, Erik Dutson, Sammy Saab. Liver Transplantation and Bariatric Surgery. Clinics in Liver Disease 2017; 21(2): 215 doi: 10.1016/j.cld.2016.12.001
|
| 124 |
|
| 125 |
Winnie S. Y. Tan, Adrienne M. Young, Alexandra L. Di Bella, Tracy Comans, Merrilyn Banks. Exploring the Impact of Obesity on Health Care Resources and Coding in the Acute Hospital Setting: A Feasibility Study. Healthcare 2020; 8(4): 459 doi: 10.3390/healthcare8040459
|
| 126 |
E.R.F. Siqueira, C.P.M.S. Oliveira, M.L. Correa-Giannella, J.T. Stefano, A.M. Cavaleiro, M.A.H.Z. Fortes, M.T.C. Muniz, F.S. Silva, L.M.M.B. Pereira, F.J. Carrilho. MTP -493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients. Brazilian Journal of Medical and Biological Research 2012; 45(1): 72 doi: 10.1590/S0100-879X2011007500160
|
| 127 |
Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. . Advances in Clinical Chemistry 2013; 61: 67 doi: 10.1016/B978-0-12-407680-8.00004-X
|
| 128 |
Jessica M. Ellis, David S. Paul, Michael A. DePetrillo, Bhanu P. Singh, David E. Malarkey, Rosalind A. Coleman. Mice Deficient in Glycerol-3-Phosphate Acyltransferase-1 Have a Reduced Susceptibility to Liver Cancer. Toxicologic Pathology 2012; 40(3): 513 doi: 10.1177/0192623311432298
|
| 129 |
Vlad Ratziu. Treatment of NASH with ursodeoxycholic acid: Pro. Clinics and Research in Hepatology and Gastroenterology 2012; 36: S41 doi: 10.1016/S2210-7401(12)70020-7
|